Kronos Bio

YTD

ALL

Why Robinhood?

You can watch Kronos Bio and buy or sell other stocks, ETFs, and their options commission-free!

About KRON

Kronos Bio, Inc. is a clinical development biopharmaceutical company. It engages in the business of developing therapeutics that target dysregulated transcription that causes cancer and other serious diseases.

CEO

Deborah A. Knobelman, PhD

CEODeborah A. Knobelman, PhD

Employees

Employees10

Headquarters

San Mateo, California

HeadquartersSan Mateo, California

Founded

2017

Founded2017

Employees

Employees10

KRON Key Statistics

Market cap

53.65M

Market cap53.65M

Price-Earnings ratio

-0.82

Price-Earnings ratio-0.82

Dividend yield

—

Dividend yield—

Average volume

6.01K

Average volume6.01K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.60

52 Week high$1.60

52 Week low

$0.65

52 Week low$0.65

People also own

Based on the portfolios of people who own KRON. This list is generated using Robinhood data, and it’s not a recommendation.